Refine Search
(5)
(8)
(17)
(27)

Hyperlipidemia - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hyperlipidemia - Pipeline Review, H2 2016’, provides an overview of the Hyperlipidemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hyperlipidemia, ...

Lipodystrophy - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Lipodystrophy - Pipeline Review, H2 2016’, provides an overview of the Lipodystrophy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Lipodystrophy, com...

Ageing - Pipeline Review, H2 2016

  • $2,000
  • October 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ageing - Pipeline Review, H2 2016’, provides an overview of the Ageing pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ageing, complete with analysis b...

Hypertriglyceridemia - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hypertriglyceridemia - Pipeline Review, H2 2016’, provides an overview of the Hypertriglyceridemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hype...

Diabetic Retinopathy - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Retinopathy - Pipeline Review, H1 2018’, provides an overview of the Diabetic Retinopathy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Diab...

Obesity - Pipeline Review, H1 2018

  • $2,500
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Obesity - Pipeline Review, H1 2018’, provides an overview of the Obesity pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Obesity, complete with analysi...

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2018

  • $2,500
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2018’, provides an overview of the Type 1 Diabetes (Juvenile Diabetes) pipeline landscape.

The report provides comprehensive information on the therapeut...

Type 2 Diabetes - Pipeline Review, H1 2018

  • $2,500
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2018’, provides an overview of the Type 2 Diabetes pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Type 2 Diabete...

Hypercholesterolemia - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hypercholesterolemia - Pipeline Review, H1 2018’, provides an overview of the Hypercholesterolemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hype...

Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2018’, provides an overview of the Pituitary ACTH Hypersecretion (Cushing Disease) pipeline landscape.

The report provides comprehensive info...

Hyperinsulinemia - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hyperinsulinemia - Pipeline Review, H1 2018’, provides an overview of the Hyperinsulinemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hyperinsulin...

Hyperglycemia - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hyperglycemia - Pipeline Review, H1 2018’, provides an overview of the Hyperglycemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hyperglycemia, com...

Familial Amyloid Neuropathies - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Familial Amyloid Neuropathies - Pipeline Review, H1 2018’, provides an overview of the Familial Amyloid Neuropathies pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Cushing's Syndrome - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cushing's Syndrome - Pipeline Review, H1 2018’, provides an overview of the Cushing's Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Hyperuricemia - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hyperuricemia - Pipeline Review, H2 2018’, provides an overview of the Hyperuricemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hyperuricemia, com...